Logo image of HRC

Hill Rom Holdings (HRC) Stock Fundamental Analysis

NYSE:HRC - New York Stock Exchange, Inc. - Common Stock

155.96  +0.05 (+0.03%)

After market: 155.96 0 (0%)

Fundamental Rating

2

Taking everything into account, HRC scores 2 out of 10 in our fundamental rating. HRC was compared to 189 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of HRC have multiple concerns. HRC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HRC was profitable.
HRC Yearly Net Income VS EBIT VS OCF VS FCFHRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M 500M

1.2 Ratios

Industry RankSector Rank
ROA 4.97%
ROE 13.22%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HRC Yearly ROA, ROE, ROICHRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 5 10 15

1.3 Margins

Industry RankSector Rank
OM 17.4%
PM (TTM) 8.23%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HRC Yearly Profit, Operating, Gross MarginsHRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 10 20 30 40 50

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, HRC has less shares outstanding
Compared to 1 year ago, HRC has a worse debt to assets ratio.
HRC Yearly Shares OutstandingHRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M
HRC Yearly Total Debt VS Total AssetsHRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 3.60 indicates that HRC is not in any danger for bankruptcy at the moment.
HRC has a Debt/Equity ratio of 0.97. This is a neutral value indicating HRC is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Altman-Z 3.6
ROIC/WACCN/A
WACCN/A
HRC Yearly LT Debt VS Equity VS FCFHRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B

2.3 Liquidity

HRC has a Current Ratio of 1.38. This is a normal value and indicates that HRC is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.05 indicates that HRC should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.05
HRC Yearly Current Assets VS Current LiabilitesHRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B

More info and screens

5

3. Growth

3.1 Past

HRC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.10%, which is quite good.
HRC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.30% yearly.
The Revenue has been growing slightly by 4.78% in the past year.
The Revenue has been growing slightly by 2.60% on average over the past years.
EPS 1Y (TTM)14.1%
EPS 3Y9.93%
EPS 5Y13.3%
EPS Q2Q%42.74%
Revenue 1Y (TTM)4.78%
Revenue growth 3Y1.96%
Revenue growth 5Y2.6%
Sales Q2Q%13.13%

3.2 Future

Based on estimates for the next years, HRC will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.11% on average per year.
Based on estimates for the next years, HRC will show a small growth in Revenue. The Revenue will grow by 5.87% on average per year.
EPS Next Y3.85%
EPS Next 2Y7.49%
EPS Next 3Y9.22%
EPS Next 5Y10.11%
Revenue Next Year3.75%
Revenue Next 2Y4.37%
Revenue Next 3Y5.68%
Revenue Next 5Y5.87%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HRC Yearly Revenue VS EstimatesHRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B
HRC Yearly EPS VS EstimatesHRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 24.72, HRC is valued on the expensive side.
The average S&P500 Price/Earnings ratio is at 29.62. HRC is around the same levels.
HRC is valuated rather expensively with a Price/Forward Earnings ratio of 23.80.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, HRC is valued at the same level.
Industry RankSector Rank
PE 24.72
Fwd PE 23.8
HRC Price Earnings VS Forward Price EarningsHRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.16
HRC Per share dataHRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HRC does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)6.41
PEG (5Y)1.86
EPS Next 2Y7.49%
EPS Next 3Y9.22%

More info and screens

4

5. Dividend

5.1 Amount

HRC has a yearly dividend return of 0.62%, which is pretty low.
With a Dividend Yield of 0.62, HRC pays less dividend than the S&P500 average, which is at 2.27.
Industry RankSector Rank
Dividend Yield 0.62%

5.2 History

The dividend of HRC is nicely growing with an annual growth rate of 6.42%!
HRC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.42%
Div Incr YearsN/A
Div Non Decr YearsN/A
HRC Yearly Dividends per shareHRC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 0.2 0.4 0.6 0.8

5.3 Sustainability

24.95% of the earnings are spent on dividend by HRC. This is a low number and sustainable payout ratio.
The dividend of HRC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP24.95%
EPS Next 2Y7.49%
EPS Next 3Y9.22%
HRC Yearly Income VS Free CF VS DividendHRC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M
HRC Dividend Payout.HRC Dividend Payout, showing the Payout Ratio.HRC Dividend Payout.PayoutRetained Earnings

More info and screens

Hill Rom Holdings

NYSE:HRC (12/10/2021, 8:15:43 PM)

After market: 155.96 0 (0%)

155.96

+0.05 (+0.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)02-15 2022-02-15/bmo
Inst Owners0%
Inst Owner Change0%
Ins Owners0.66%
Ins Owner Change0%
Market Cap10.42B
Analysts51.43
Price Target159.12 (2.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.62%
Yearly Dividend0.94
Dividend Growth(5Y)6.42%
DP24.95%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 24.72
Fwd PE 23.8
P/S 3.45
P/FCF N/A
P/OCF N/A
P/B 5.54
P/tB N/A
EV/EBITDA 17.16
EPS(TTM)6.31
EY4.05%
EPS(NY)6.55
Fwd EY4.2%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS45.2
BVpS28.15
TBVpSN/A
PEG (NY)6.41
PEG (5Y)1.86
Profitability
Industry RankSector Rank
ROA 4.97%
ROE 13.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 17.4%
PM (TTM) 8.23%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 1.05
Altman-Z 3.6
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.1%
EPS 3Y9.93%
EPS 5Y13.3%
EPS Q2Q%42.74%
EPS Next Y3.85%
EPS Next 2Y7.49%
EPS Next 3Y9.22%
EPS Next 5Y10.11%
Revenue 1Y (TTM)4.78%
Revenue growth 3Y1.96%
Revenue growth 5Y2.6%
Sales Q2Q%13.13%
Revenue Next Year3.75%
Revenue Next 2Y4.37%
Revenue Next 3Y5.68%
Revenue Next 5Y5.87%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A